Sintx Technologies, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
SINT$1.55+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (unaudited)
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(8,149) | $(9,329) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation expense | 245 | 727 |
| Impairment of Armor | 64 | 4,457 |
| Amortization of right of use asset | 246 | 428 |
| Loss on disposal of subsidiary | 25 | - |
| Amortization of intangible assets | 11 | 4 |
| Stock based compensation - Employee | 739 | 75 |
| Stock based compensation - Non-employee | 606 | - |
| Change in fair value of derivative liabilities | 166 | (3,459) |
| Bad debt (recoveries) expense | (1) | 13 |
| Loss (gain) on disposal of equipment | (352) | 8 |
| Changes in operating assets and liabilities: | ||
| Trade accounts receivable | (13) | 332 |
| Prepaid expenses and other current assets | 70 | 241 |
| Inventories | 110 | 171 |
| Accounts payable and accrued liabilities | 247 | (788) |
| Other liabilities | 34 | (2) |
| Payments on operating lease liability | (275) | (396) |
| Net cash used in operating activities | (6,227) | (7,518) |
| Cash flows from investing activities | ||
| Purchase of property and equipment | (143) | (544) |
| Proceeds from acquisition of Sinaptic Surgical | 750 | - |
| Proceeds from notes receivable, net of imputed interest | - | 320 |
| Proceeds from sale of property and equipment | 352 | 20 |
| Disposal of property and equipment, net of cash received | (4) | - |
| Net cash provided by (used in) investing activities | 955 | (204) |
| Cash flows from financing activities | ||
| Proceeds from issuance of warrant derivative liabilities | - | 3,366 |
| Proceeds from issuance of common stock and prefunded warrants, net of cash fees | 4,380 | 6,075 |
| Proceeds from exercise of warrants, net of cash fees, and deposit for stock issuance (in other current liabilities) | 3,624 | - |
| Purchase of common stock into treasury | (133) | - |
| Proceeds from issuance of warrants in connection with exercise of warrants | 206 | - |
| Proceeds from issuance of common stock in connection with exercise of warrants | - | 2 |
| Payments on debt | (153) | (247) |
| Net cash provided by financing activities | 7,924 | 9,196 |
| Net increase in cash and cash equivalents | 2,652 | 1,474 |
| Cash and cash equivalents at beginning of period | 3,598 | 3,340 |
| Cash and cash equivalents at end of period | $6,250 | $4,814 |
| Noncash investing and financing activities | ||
| Debt issued for prepaid insurance | $180 | $335 |
| Deemed dividend related to warrant inducement and issuance of warrants | 6,719 | - |
| Agent warrant offering cost allocated to equity | - | 13 |
| Right of use asset for amended lease liability – increase | - | 307 |
| Reduction of derivative liability upon exercise of warrants | - | 1 |
| Supplemental cash flow information | ||
| Cash paid for interest | $40 | $15 |
SINTX TECHNOLOGIES, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.